期刊文献+

计算法合成右侧胸部心电图导联对肺动脉高压的检测和评价 被引量:2

Detection and evaluation of pulmonary artery hypertension using a calculation method-synthesized right-sided chest ECG lead
下载PDF
导出
摘要 目的:评估运用由12导联心电图(ECG)信息所产生的计算法合成右胸ECG(syn-ECG)评价肺动脉高压(PAH)的有效性。方法:选择45例PAH患者的Syn-ECG(PAH组),与45例年龄和性别相当的正常人的Syn-ECG(正常对照组)进行对比分析。结果:肺动脉高压患者Syn-ECG的R波振幅和R/S比值均显著高于正常对照组(P均=0.001)。Pearson相关分析显示,与标准导联V1(r=0.425,P=0.004)相比,Syn-ECG的R波振幅与估测的肺动脉收缩压(PASP)显示了更好的相关性(r=0.509~0.609,P均=0.001)。受试者工作特征曲线表明,在Syn-V5R中,以R波振幅0.125mV为界值[曲线下面积(AUC)=0.802,P=0.001],预测PAH的敏感度为0.622,特异性为0.911;以R/S比值0.405为界值(AUC=0.818,P=0.001),预测PAH敏感度为0.733,特异性为0.867。结论:与标准12导联ECG相比,Syn-ECG提高了诊断肺动脉高压的准确度,为临床评估肺动脉高压提供了简便、有效的方法。 Objective:To assess effectiveness of 12-lead ECG information produced calculation method-synthesized right chest ECG(Syn-ECG)in evaluation of pulmonary artery hypertension(PAH).Methods:Syn-ECG of 45 PAH patients(PAH group)were compared and analyzed with Syn-ECG of 45 healthy subjects with corresponding aged and gender(normal control group).Results:R wave amplitude and R/S ratio of Syn-ECG in PAH group were significantly higher than those of normal control group(P=0.001 all).Pearson correlation analysis indicated that compared with standard lead V1(r=0.425,P=0.004),R wave amplitude of Syn-ECG possessed better correlation with estimated pulmonary artery systolic pressure(PASP)(r=0.509-0.609,P=0.001 all).ROC indicated that in Syn-V5R,with R wave amplitude=0.125mV as cutoff point(AUC=0.802,P=0.001),its sensitivity and specificity was 0.622,0.911 respectively in predicting PAH;with R/S ratio=0.405 as cutoff point(AUC=0.818,P=0.001),its sensitivity and specificity was 0.733,0.867 respectively in predicting PAH.Conclusion:Compared with standard 12-lead ECG,Syn-ECG increases accuracy in diagnosing PAH,provides simple and effective method for assessing PAH in clinic.
作者 张苏明 陈慧 郭冠军 孙步高 ZHANG Su-ming;CHEN Hui;GUO Guan-jun;SUN Bu-gao(Cardiac Function Room,Nanjing Drum Tower Hospital,Nanjing,Jiangsu,210008,China)
出处 《心血管康复医学杂志》 CAS 2021年第2期199-203,共5页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 高血压 肺性 心电描记术 诊断 Hypertension,Pulmonary Electrocardiography Diagnosis
  • 相关文献

参考文献2

二级参考文献32

  • 1陆慰萱,季颖群.肺动脉高压的研究进展[J].中华内科杂志,2004,43(11):874-877. 被引量:10
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 3荆志成.我国肺动脉高压专家共识阐释[J].中国实用内科杂志,2007,27(4):246-249. 被引量:54
  • 4Archer SL, Michelakis ED. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension [J] . N Engl J Med, 2009, 361 (19): 1864-1871.
  • 5Ghofrani HA, Pepke-Zaba J, Barbera JA, et al. Nitric oxide pathway and phosphodiesterase inhihitors in pulmonary arterial hypertension [J] . J Am Coll Cardiol, 2004, 43 (12 Suppl S) : 68S-72S.
  • 6Mutlak D, Aronson D, Lessick J. Functional tricuspid regurgi- tation in patients with pulmonary hypertension: is pulmonary ar tery pressure the only determinant of regurgitation severity [J]. Chest, 2009, 135 (1): 115-121.
  • 7Badesch DB, Abman SH, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension., updated ACCP evidence- based clinical practice guidelines [J]. Chest, 2007, 131 (6): 1917-1928.
  • 8Aizawa K, Hanaoka T, Kasai H , et al. Long-term vardenafil therapy improves hemodynamics in patients with pulmonary hy- pertension [J] . HypertensRes, 2006, 29 (2) : 123-128.
  • 9Jing ZC, Yu ZX, Shen JY, et al. Vardenafil in pulmonary arte rial hypertension: a randomized, double-blind, placebo-con- trolled study [J]. Am J Respir Crit Care Med, 2011, 183 (12) : 1723-1729.
  • 10Gali~ N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. [J]. N Engl J Med, 2005, 353 (20): 2148-2157.

共引文献18

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部